August 23, 2021 Allergy/Immunology AstraZeneca is soon to publish results from its pre-exposure prophylaxis trial about anti-Covid antibodies given IM to people with comorbid states that reduce the immune response from vaccines. Reduced severe symptomatic risk (relative) by 77%.
March 10, 2021 Allergy/Immunology New T-cell test to determine past exposure to SARS-CoV-2 is cool science but not a game changer. It may help answer why some become long-haulers after infection while others do not and it is a starting point for discovery and treatment research.
February 3, 2021 Bioengineering Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.
September 3, 2020 Epidemiology Excellent application of science as supercomputer genetic analysis generates plausible hypothesis that unifies the disparate Covid-19 symptoms into a coherent whole. Clinical studies required to prove the claim.
May 22, 2020 Clinical Research Is this hypothesis the ACE in the hole that explains why children account for so few cases of SARS-CoV-2? Verification and further evaluation required.
May 6, 2020 Epidemiology Los Alamos Lab uses computational analysis of 6000 coronavirus sequences to conclude that a mutated strain is now dominant. Clinical implications remain unknown and study needs to be peer -reviewed and published.
April 13, 2020 Epidemiology Spartan Bioscience receives Health Canada approval of new SARS-Cov2 testing devices. We discuss the implications for public health policy.
November 4, 2019 Bioengineering Must-listen-to podcast reveals the greed behind the unsubstantiated claims of stem cell treatments in the U.S. that have harmed patients
June 21, 2018 Bioengineering Mouse study shows that caffeine can stimulate diabetes drug release from implant. Overhype drives this article and raises questions how you would control caffeine dosing and why use it in the first place.